| News |
April
2008 |
Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses
for symptomatic heart failure. Borggrefe et al.,
Eur Heart J 2008 29: 1019-1028 |
June
2007 |
Patient Enrollment Completed in FIX-HF-5 Clinical Trial |
November 2006 |
Enrollment in Phase II of FIX-HF-5 reaches three quarters point with the 314th patient enrolled on November 17 at Riverside Medical, VA. |
November 2006 |
Cardiac Contractility Modulation Technology presented at the “Device Therapy in Heart Failure” session, AHA Scientific Sessions, 12 Nov 2006, Chicago, IL |
October 2006 |
FIX-HF-5 Phase I results published the Heart Rhythm Journal |
September 2006 |
FIX-CHF-4 data presented at the Late Breaking Clinical Trials session at the 10th Annual Scientific meeting of the Heart Failure Society of America, September 13, Seattle, WA |
September 2006 |
Data on Cardiac Contractility Modulation and gene expression presented at the World Congress of Cardiology 2006, Barcelona, Spain |
August
2006 |
Completion of follow-up period for FIX-CHF-4 study in Europe |
July
2006 |
First commercial use of Optimizer III in Europe |
June
2006 |
FIX-CHF-4 data accepted for Late Breaking Clinical Trials at the 10th Annual Scientific meeting of the Heart Failure Society of America (September 10-13, Seattle, WA) |
June
2006 |
First FIX-HF-5 publication – manuscript of Phase I results accepted for publication in the Heart Rhythm Journal (October 06 issue) |
May
2006 |
First FIX-HF-5 abstract - results of Phase I accepted for presentation at the 10th Annual Scientific meeting of the Heart Failure Society of America (September 10-13, Seattle, WA) |
May
2006 |
Five different presentations regarding Cardiac Contractility Modulation (CCM) Technology discussed at the 27th Annual Heart Rhythm Society Scientific Sessions |
May
2006 |
Enrollment in Phase II of FIX-HF-5 reaches half way point with 209th patient enrolled on May 26th at Heart Care Associates in Milwaukee. |
December 2005 |
Impulse Dynamics Obtains CE Mark for Optimizer III System |
December 2005 |
End of enrollment to FIX-CHF-4 study in Europe, a multi-center, randomized, double-blind crossover study evaluating the safety and efficacy of the Optimizer II and III Systems |
May
2005 |
Data on Cardiac Contractility Modulation (CCM) Technology presented at the 26th Annual Heart Rhythm Society Scientific Sessions (.pdf) |
April
2005 |
First U.S. heart-disease patient implanted with device. New York Post Article April 13, 2005. |
April
2005 |
Initial implantation launches US Phase II of Optimizer FIX-HF-5 study (.pdf) |
January 2005 |
Expansion of FIX-CHF-4 study to include 250 patients. |
December 2004 |
Last patient enrolled of Phase I of the FIX-HF-5 Clinical Study |
October 2004 |
Start FIX-HF-10 Long-term evaluation (1 year) safety and efficacy study of Optimizer III. |
September 2004 |
Completion FIX HF-7 (March to September) Safety study Optimizer III. |
June
2004 |
The first implant of the in FIX-HF-5 clinical study, Cardiac Heart Arrhythmia Research, Austin Texas |
May
2004 |
Approval and start of FIX-HF-5 in the United States with 10 sites including 50 patients |
March
2004 |
World wide first Optimizer III rechargeable implantation in Bochum , Germany and start of FIX-HF-7 Optimizer III safety study. |
May
2002 |
FIX-CHF-4 Clinical study started in Europe . |
December 2002 |
Impulse Dynamics Obtains CE Mark for Optimizer II System for the Treatment of Congestive Heart Failure. |
May
2002 |
Impulse Dynamics Launches Safety and Efficacy Study of the Optimizer II System for the Treatment of Congestive Heart Failure. |
May
2002 |
Impulse Dynamics Completes FIX-HF-3 European Clinical Trials for Optimizer II System for the Treatment of Congestive Heart Failure. |
July
2001 |
Impulse Dynamics Initiates FIX-HF-3 Study for the Evaluation of the Functionality and Safety of the OPIMIZER II System for the Treatment of Congestive Heart Failure. |
